Basic Information
| LncRNA/CircRNA Name | MIR155HG |
| Synonyms | MIR155HG, BIC, MIRHG2, NCRNA00172 |
| Region | GRCh38_21:25561909-25575168 |
| Ensemble | ENSG00000234883 |
| Refseq | NR_001458 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | T and NK cell lymphoma |
| ICD-0-3 | C86.0 |
| Methods | qPCR |
| Sample | natural killer/T-cell lymphoma tissues |
| Expression Pattern | differential expression |
| Function Description | These findings suggest that ZFAS1 and other dysregulated long non-coding RNAs may be involved in natural killer/T-cell lymphoma pathobiology through regulation of cancer-related genes, and loss-of-PRDM1 expression in natural killer/T-cell lymphomas may contribute to overexpression of MIR155HG; thereby promoting tumorigenesis. |
| Pubmed ID | 28468592 |
| Year | 2017 |
| Title | Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1 |
External Links
| Links for MIR155HG | GenBank HGNC NONCODE |
| Links for T and NK cell lymphoma | OMIM COSMIC |